Related Experiment Videos
Hypercalcaemia in rheumatoid arthritis revisited
S H Ralston1, W D Fraser, J Jankowski
1Centre for Rheumatic Diseases, Glasgow Royal Infirmary.
Annals of the Rheumatic Diseases
|January 1, 1990
Summary
Hypercalcemia causes in rheumatology patients are similar to the general population, with primary hyperparathyroidism being the most frequent diagnosis. This challenges previous beliefs about rheumatoid arthritis as a direct cause.
Area of Science:
- Rheumatology
- Endocrinology
- Internal Medicine
Background:
- Hypercalcemia is a complex condition with various underlying causes.
- Previous research suggested a potential link between rheumatoid arthritis and hypercalcemia.
- Understanding the prevalence and mechanisms of hypercalcemia in specific patient populations is crucial for accurate diagnosis and management.
Purpose of the Study:
- To investigate the prevalence and etiological factors of hypercalcemia in patients attending a rheumatology referral center.
- To compare the causes of hypercalcemia in rheumatological patients with those reported in the general population.
- To evaluate the association between rheumatoid arthritis and hypercalcemia.
Main Methods:
- A prospective screening of 251 consecutive patients over three months.
- A retrospective analysis of 39 hypercalcemic patients from the preceding 12 months.
- Comprehensive diagnostic workup for all identified hypercalcemic cases.
Main Results:
- Prospective screening identified one case of hypercalcemia due to primary hyperparathyroidism.
- Retrospective analysis revealed that 97% of hypercalcemic patients had a known underlying cause.
- The most common causes were primary hyperparathyroidism (62%), thiazide treatment (13%), cancer (8%), and immobility (8%).
Conclusions:
- The etiological spectrum of hypercalcemia in rheumatological patients mirrors that of the general population.
- Hypercalcemia is not a frequent complication of rheumatoid arthritis itself, contrary to some previous reports.
- Primary hyperparathyroidism remains the leading cause of hypercalcemia in this cohort.